Meng, F., Kennedy, L., Hargrove, L., Demieville, J., Jones, H., Madeka, T., . . . Francis, H. (2018). Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2(−/−) mice and human primary sclerosing cholangitis. Lab Invest.
Chicago Style citaatMeng, Fanyin, et al. "Ursodeoxycholate Inhibits Mast Cell Activation and Reverses Biliary Injury and Fibrosis in Mdr2(−/−) Mice and Human Primary Sclerosing Cholangitis." Lab Invest 2018.
MLA citatieMeng, Fanyin, et al. "Ursodeoxycholate Inhibits Mast Cell Activation and Reverses Biliary Injury and Fibrosis in Mdr2(−/−) Mice and Human Primary Sclerosing Cholangitis." Lab Invest 2018.
Let op: Deze citaties zijn niet altijd 100% accuraat.